SCHEMBL8906069

SCHEMBL8906069

[O]CCOCCCc1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.50
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
HSD17B10 Q99714 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
HRH3 Q9Y5N1 2/20 0.43
HRH4 Q9H3N8 1/20 0.43
NAAA Q02083 1/20 0.43
LMNA P02545 2/20 0.42
TAAR1 Q96RJ0 1/20 0.42
ALDH1A1 P00352 1/20 0.42
ALOX15 P16050 1/20 0.42
FKBP1A P62942 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7445422 0.91 HRH1 (0.58) HRH1CYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL8907011 0.89 HRH1 (0.50) HRH1CYP1A2CYP2C19SMN1; SMN2CYP2D6
SCHEMBL7449242 0.85 HRH1 (0.61) HRH1CYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL29263687 0.84 HRH1 (0.71) HRH1CYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL7448741 0.84 HRH1 (0.65) HRH1CYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL1807177 0.84 HRH1 (0.65) HRH1CYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL7452998 0.84 HRH1 (0.65) HRH1CYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL7449958 0.84 HRH1 (0.65) HRH1CYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL8045802 0.83 HRH1 (0.50) HRH1CYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL14305751 0.83 CYP2D6 (0.50) HRH1CYP1A2CYP2C19SMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed